Post by
red2000 on Jan 26, 2021 1:00pm
Intellectual property
From Sedar.com
Management’s Discussion & Analysis For the year ended July 31, 2020
Intellectual property The Company strives to protect its intellectual property in established and emerging markets around the world as warranted.
MedMira’s intellectual property portfolio for its Rapid Vertical Flow Technology and the methodology behind its rapid diagnostics includes the following:
Patent # Title Jurisdiction
9,164,087 Rapid Diagnostic Device, assay and multifunctional Buffer United States
9,086,410 Downward or vertical flow diagnostic device and assay United States
8,025,850 Rapid Diagnostic Device, Assay and Multifunctional Buffer United States
3 8,287,817 Rapid Diagnostic Device, Assay and Multifunctional Buffer United States
8,586,375 Rapid Diagnostic Device, Assay and Multifunctional Buffer United States
7,531,362 Rapid Diagnostic Device, Assay and Multifunctional Buffer United States
D706945 Diagnostic Device United States D706466 Diagnostic Device United States EP1417489 Rapid Diagnostic Device and Assay Europe
ZL02819646.5 Rapid Diagnostic Device and Assay China
2,493,616 Rapid Diagnostic Device, Assay and Multifunctional Buffer Canada
The Company has other patents pending patents in the U.S. as well as two design patents in force or pending in eight markets.
The Company’s corporate and product brand names are protected by trademarks in the U.S. and Canada